Effects of cognitive stimulation on neuropsychiatric symptoms in elderly with Alzheimer's disease: A systematic review
ABSTRACTIntroduction:Neuropsychiatric symptoms are frequent in Alzheimer's disease and negatively affect patient quality of life.Objective:To assess the effectiveness of cognitive stimulation on neuropsychiatric symptoms in elderly patients with Alzheimer's disease.Methods:The included art...
| Autores: | , , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2016 |
| País: | Brasil |
| Institución: | Universidade Estadual Paulista (UNESP) |
| Repositorio: | Repositório Institucional da UNESP |
| Idioma: | inglés |
| OAI Identifier: | oai:repositorio.unesp.br:11449/157915 |
| Acceso en línea: | http://dx.doi.org/10.1590/S1980-5764-2016DN1003003 http://hdl.handle.net/11449/157915 |
| Access Level: | acceso abierto |
| Palabra clave: | Alzheimer's disease depression apathy anxiety dementia cognitive stimulation doença de Alzheimer depressão apatia ansiedade demência estimulação cognitiva |
| Sumario: | ABSTRACTIntroduction:Neuropsychiatric symptoms are frequent in Alzheimer's disease and negatively affect patient quality of life.Objective:To assess the effectiveness of cognitive stimulation on neuropsychiatric symptoms in elderly patients with Alzheimer's disease.Methods:The included articles were reviewed between December 2015 and June 2016, and the inclusion criteria were: (1) studies involving older adults diagnosed with Alzheimer's disease; (2) studies published in English, Spanish or Portuguese; (3) studies that determined the effect of cognitive stimulation on neuropsychiatric symptoms in elderly patients with Alzheimer's disease; (4) controlled trials.Results:Out of the total 722, 9 articles matched the inclusion criteria. Depression, apathy and anxiety were the most frequent symptoms.Conclusion:Studies reported significant results post-treatment, suggesting cognitive stimulation can be effective for these neuropsychiatric symptoms, thus improving the quality of life of Alzheimer's disease patients and their caregivers. |
|---|